window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Technology and platforms

  • Biomanufacturing,Biotech,Drug Development,Research & Development,Technology and platforms

    Abselion extends Amperia platform with Protein G kit for broader antibody quantification

    Abselion has expanded its Amperia benchtop platform with a new [...]

    September 29, 2025
  • Biomanufacturing,Biotech,Research & Development,Supply Chain & Logistics,Technology and platforms

    Miebach Consulting doubles Oxfordshire footprint to support life sciences supply chains at Abingdon Science Park

    Categories: Biomanufacturing, Biotech, Supply Chain & Logistics, Technology and platforms, [...]

    September 26, 2025
  • Biologics & Biosimilars,Biotech,Clinical Trials,Medical devices,Oncology,Pharmaceuticals and therapeutics,Technology and platforms

    Xeltis poised for commercialization following positive EU pivotal trial results

    Xeltis has announced successful clinical data from its aXess EU [...]

    September 26, 2025
  • Biotech,European biotech,Partnerships & Funding,Pharmaceuticals and therapeutics,Supply Chain & Logistics,Technology and platforms

    Atelerix signs deal with CliniSciences to expand access to cryo-free cell preservation in Europe and North Africa

    Atelerix has signed a new distribution agreement with CliniSciences that [...]

    September 26, 2025
  • Cell & Gene Therapy,Clinical Development,Oncology,Technology and platforms

    N4 Pharma and SRI demonstrate targeted Nuvec delivery to lung cancer cells

    N4 Pharma has reported new data from its collaboration with [...]

    September 24, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,Drug Development,Pharmaceuticals and therapeutics,Technology and platforms

    ReiThera: Commercial CDMO capabilities key to manage ‘volatile’ biotech market

    ReiThera will begin commercial production in 2026, a milestone the [...]

    September 25, 2025
  • Clinical Development,Clinical studies,Data Management,Technology and platforms

    REDCap Cloud 2.0 launched to harmonize clinical trial and real-world data for AI-driven research

    REDCap Cloud has launched version 2.0, a clinical trial data [...]

    September 24, 2025
  • Artificial Intelligence,Cell & Gene Therapy,Drug Development,Research & Development,Technology and platforms

    AISB Network expands Federated OpenFold3 initiative with three new pharma contributors

    The AI Structural Biology (AISB) Network, powered by Apheris GmbH, [...]

    September 23, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics,Technology and platforms

    RION partners with Lonza to scale manufacturing of exosome-based therapeutics

    RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived [...]

    September 23, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics,Supply Chain & Logistics,Technology and platforms

    Merck opens climate-neutral €150 million filter manufacturing facility in Ireland

    Merck has inaugurated its first climate-neutral manufacturing facility in Ireland, [...]

    September 23, 2025
Previous111213Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics
    Categories: Clinical Development, Neurosciences, Partnerships & Funding, Research & Development
  • AC Immune amends Lilly collaboration on Tau small molecules for Alzheimer’s disease
    Categories: Clinical Development, Neurosciences, Partnerships & Funding, Research & Development
  • Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal
    Categories: Biologics & Biosimilars, Clinical Trials, Manufacturing, Oncology, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top